A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Teplizumab | Teplizumab is a humanized anti-CD3 monoclonal antibody indicated to delay the onset of Stage 3 type 1 diabetes in patients with Stage 2 type 1 diabetes. Synonyms: MGA-031; PRV-031; Tzield. CAS No. 876387-05-2. |  |
| Teplizumab | Teplizumab (MGA-031) is a Fc receptor non-binding anti-human CD3 monoclonal antibody. Teplizumab reduces the loss of beta-cell function. Teplizumab can be used in the research of type 1 diabetes [1] [2]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: MGA-031; PRV-031. CAS No. 876387-05-2. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99222. |  |
| Teplow's Amyloid β-Protein (1-40) (scrambled II) | Teplow's Amyloid β-Protein (1-40) (scrambled II) is a specially designed negative control in the Abeta40 study. Teplow's Amyloid β-Protein (1-40) does not exhibit some of the phenomena regularly observed by Abeta40 (fiber formation, oligomerization, toxicity to neurons), and has a relatively flat hydropathy profile, which may have been an advantage in some studies, for example, to avoid nonspecific interactions with cell membranes. ''Scrambled'' means that it contains the same amino acids as Abeta40, but in a different order. Synonyms: β-Amyloid (1-40) (scrambled II); H-Tyr-His-Ala-Gly-Val-Asp-Lys-Glu-Val-Val-Phe-Asp-Glu-Gly-Gly-Ala-Glu-His-Gly-Leu-Ala-Gln-Lys-Ile-Val-Arg-Gly-Phe-Gly-Val-Ser-Asp-Val-Ser-Met-Ile-His-Asn-Leu-Phe-OH. Grades: ≥95%. CAS No. 1987844-71-2. Molecular formula: C194H295N53O58S. Mole weight: 4329.86. | |
| Teplow's Amyloid β-Protein (1-42) (scrambled II) | Teplow's Amyloid β-Protein (1-42) (scrambled II) is a specially designed negative control in the Abeta42 study. Teplow's Amyloid β-Protein (1-42) does not exhibit some of the phenomena regularly observed by Abeta42 (fiber formation, oligomerization, toxicity to neurons), and has a relatively flat hydropathy profile, which may have been an advantage in some studies, for example, to avoid nonspecific interactions with cell membranes. ''Scrambled'' means that it contains the same amino acids as Abeta42, but in a different order. Synonyms: β-Amyloid (1-42) (scrambled II); H-Tyr-His-Ala-Gly-Val-Asp-Lys-Glu-Val-Val-Phe-Asp-Glu-Gly-Ala-Gly-Ala-Glu-His-Gly-Leu-Ala-Gln-Lys-Ile-Val-Arg-Gly-Phe-Gly-Val-Ser-Asp-Val-Ser-Met-Ile-His-Ile-Asn-Leu-Phe-OH. Grades: ≥95%. CAS No. 1987844-92-7. Molecular formula: C203H311N55O60S. Mole weight: 4514.03. | |
| Tepotinib | Tepotinib (EMD-1214063) is an orally active and highly selective, reversible, ATP-competitive c-Met inhibitor with an IC 50 of 3 nM, >200-fold selective for c-Met than IRAK4, TrkA, Axl, IRAK1, and Mer. Tepotinib inhibits c-Met phosphorylation and induces autophagy. Tepotinib has antitumor effects [1] [2] [3]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: EMD-1214063. CAS No. 1100598-32-0. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-14721. | |
| Tepotinib | Tepotinib, also known as EMD 1214063 and MSC2156119, is an inhibitor of MET tyrosine kinase with potential antineoplastic activity. Tepotinib selectively binds to MET tyrosine kinase and disrupts MET signal transduction pathways, which may induce apoptosis in tumor cells overexpressing this kinase. The receptor tyrosine kinase MET (also known as hepatocyte growth factor receptor or HGFR), is the product of the proto-oncogene c-Met and is overexpressed or mutated in many tumor cell types. This protein plays key roles in tumor cell proliferation, survival, invasion, and metastasis, and tumor angiogenesis. Synonyms: EMD-1214063; EMD1214063; EMD 1214063; MSC-2156119; MSC2156119; MSC-2156119. CAS No. 1100598-32-0. Molecular formula: C29H28N6O2. Mole weight: 492.583. | |
| Tepoxalin | Non-steroidal anti-inflammatory drug (NSAID) with potent anti-inflammatory and analgesic properties approved for veterinary use. It has inhibitory effect on cyclooxygenase and 5-lipxygenase activity as well as inhibiting the production of cytokines in peripheral cells outside the CNS. Tepoxalin, also known as ORF-20485; RWJ-20485; is a 5-lipoxygenase inhibitor potentially for the treatment of asthma, osteoarthritis (OA). Tepoxalin has in vivo inhibitory activity against COX-1, COX-2, and 5-LOX in dogs at the current approved recommended dosage.Tepoxalin inhibits inflammation and microvascular dysfunction induced by abdominal irradiation in rats. Tepoxalin enhances the activity of an antioxidant, pyrrolidine dithiocarbamate, in attenuating tumor necrosis factor alpha-induced apoptosis in WEHI 164 cells. Group: Biochemicals. Alternative Names: 5-(4-Chlorophenyl)-N-hydroxy-1-(4-methoxyphenyl)-N-methyl-1H-pyrazole-3-propanamide; ORF 20485; RWJ 20485. Grades: Highly Purified. CAS No. 103475-41-8. Pack Sizes: 10mg. Molecular Formula: C??H??ClN?O?, Molecular Weight: 385.84. US Biological Life Sciences. |  Worldwide |
| Tepoxalin | Tepoxalin is a dual inhibitor of COX and 5-lipoxygenase (5-LO) with potent anti-inflammatory activity and a favorable gastrointestinal profile [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 103475-41-8. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-13219. | |
| Tepoxalin | Heterocyclic Organic Compound. Alternative Names: Tepoxalin;1H-Pyrazole-3-propanamide, 5-(4-chlorophenyl)-N-hydroxy-1-(4-methoxyphenyl)-N-methyl-;3-[1-(4-Methoxyphenyl)-5-(4-chlorophenyl)-1H-pyrazol-3-yl]-N-hydroxy-N-methylpropanamide;RWJ-20485;5-(4-Chlorophenyl)-N-hydroxy-1-(4-Methoxyphenyl)-N-Methyl-1H-pyrazole-3-propanaMide;ORF 20485;3-(5-(4-chlorophenyl)-1-(4-methoxyphenyl)-1H-pyrazol-3-yl)-N-hydroxy-N-methylpropanamide. CAS No. 103475-41-8. Molecular formula: C20H20ClN3O3. Mole weight: 385.849. Purity: 0.96. IUPACName: 3-[5-(4-chlorophenyl)-1-(4-methoxyphenyl)pyrazol-3-yl]-N-hydroxy-N-methylpropanamide. Canonical SMILES: CN (C (=O)CCC1=NN (C (=C1)C2=CC=C (C=C2)Cl)C3=CC=C (C=C3)OC)O. Density: 1.26 g/cm³. Catalog: ACM103475418. |  |
| Tepoxalin | Tepoxalin is a dual inhibitor of COX and 5-lipoxygenase and may be used to treat asthma and osteoarthritis (OA). Synonyms: ORF 20485; Orf-20485; Tepoxalina; Tepoxaline; RWJ 20485. Grades: 98%. CAS No. 103475-41-8. Molecular formula: C20H20ClN3O3. Mole weight: 385.84. | |
| TEPP-46 | TEPP-46 (ML-265) is a potent and selective pyruvate kinase M2 (PKM2) activator with an AC 50 of 92 nM, showing little or no effect on PKM1, PKL and PKR [1] [2] [3]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: ML-265. CAS No. 1221186-53-3. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-18657. | |
| TEPP-46 | TEPP-46, an effective sensitizer of recombinant pyruvate kinase M2, has been found to decrease the formation of tumor in a mouse xenograft model. IC50: 92 nM (AC50). Uses: Tepp-46 has been found to decrease the formation of tumor in a mouse xenograft model. Synonyms: ML265; ML-265; ML 265; CID44246499; CID-44246499; CID 44246499; NCGC00186528; NCGC 00186528; NCGC-00186528; TEPP46; TEPP 46; TEPP-46; 6-[(3-aminophenyl)methyl]-4,6-dihydro-4-methyl-2-(methylsulfinyl)-5h-thieno[2',3':4,5]pyrrolo[2,3-d]pyridazin-5-one; ML265; TEPP 46; MLS006010294. Grades: 95%. CAS No. 1221186-53-3. Molecular formula: C17H16N4O2S2. Mole weight: 372.46. | |
| Teprenone | Teprenone. Uses: For analytical and research use. Group: Impurity standards. CAS No. 6809-52-5. Molecular Formula: C23H38O. Mole Weight: 330.56. Catalog: APB6809525. |  |
| Teprenone | Teprenone. Group: Biochemicals. Alternative Names: 6,10,14,18-Tetramethyl-5,9,13,17-nonadecatetraen-2-one. Grades: Highly Purified. CAS No. 6809-52-5. Pack Sizes: 2mg, 5mg, 10mg, 25mg, 50mg. Molecular Formula: C23H38O. US Biological Life Sciences. | Worldwide |
| Teprenone | Teprenone is an anti-ulcer agent, and works as an inducer of heat shock proteins ( HSPs ). Uses: Scientific research. Group: Signaling pathways. Alternative Names: Geranylgeranylacetone. CAS No. 6809-52-5. Pack Sizes: 10 mM * 1 mL; 100 mg; 500 mg. Product ID: HY-B0779. | |
| Teprenone Epoxide | One impurity of Teprenone, which could be used as an anti-ulcerative agent and has been found to induce the expression of HSP70, HSPB8, and HSPB1. Grades: > 95%. Molecular formula: C23H38O2. Mole weight: 346.56. | |
| Teprenone Impurity 1 | One impurity of Teprenone, which could be used as an anti-ulcerative agent and has been found to induce the expression of HSP70, HSPB8, and HSPB1. Synonyms: (5Z,9E,13E)-Geranylgeranylacetone. Grades: > 95%. Molecular formula: C23H38O. Mole weight: 330.56. | |
| Teprenone Impurity 10 | One impurity of Teprenone, which could be used as an anti-ulcerative agent and has been found to induce the expression of HSP70, HSPB8, and HSPB1. Grades: > 95%. Molecular formula: C23H38O2. Mole weight: 346.56. | |
| Teprenone Impurity 11 | One impurity of Teprenone, which could be used as an anti-ulcerative agent and has been found to induce the expression of HSP70, HSPB8, and HSPB1. Grades: > 95%. Molecular formula: C23H38O2. Mole weight: 346.56. | |
| Teprenone Impurity 12 | One impurity of Teprenone, which could be used as an anti-ulcerative agent and has been found to induce the expression of HSP70, HSPB8, and HSPB1. Synonyms: (5E,9Z,13E)-Teprenone; (E,Z,E)-6,10,14,18-Tetramethyl-5,9,13,17-nonadecatetraen-2-one. Grades: > 95%. Molecular formula: C23H38O. Mole weight: 330.56. | |
| Teprenone impurity 14 | Teprenone impurity 14. Uses: For analytical and research use. Group: Impurity standards. CAS No. 3879-23-0. Molecular Formula: C23H38O. Mole Weight: 330.56. Catalog: APB3879230. | |
| Teprenone impurity 16 (Farnesylaceton) | Teprenone impurity 16 (Farnesylaceton). Uses: For analytical and research use. Group: Impurity standards. CAS No. 1117-52-8. Molecular Formula: C18H30O. Mole Weight: 262.44. Catalog: APB1117528. | |
| Teprenone Impurity 19 (Trans-Nerolidol) | Teprenone Impurity 19 (Trans-Nerolidol). Uses: For analytical and research use. Group: Impurity standards. CAS No. 40716-66-3. Molecular Formula: C15H26O. Mole Weight: 222.37. Catalog: APB40716663. | |
| Teprenone Impurity 2 | One impurity of Teprenone, which could be used as an anti-ulcerative agent and has been found to induce the expression of HSP70, HSPB8, and HSPB1. Grades: > 95%. Molecular formula: C22H36O. Mole weight: 316.53. | |
| Teprenone Impurity 21 (Cis-Nerolidol) | Teprenone Impurity 21 (Cis-Nerolidol). Uses: For analytical and research use. Group: Impurity standards. CAS No. 3790-78-1. Molecular Formula: C15H26O. Mole Weight: 222.37. Catalog: APB3790781. | |
| Teprenone impurity 22 | Teprenone impurity 22. Uses: For analytical and research use. Group: Impurity standards. CAS No. 109826-68-8. Molecular Formula: C23H40O. Mole Weight: 332.57. Catalog: APB109826688. | |
| Teprenone impurity 24 | Teprenone impurity 24. Uses: For analytical and research use. Group: Impurity standards. CAS No. 70901-63-2. Molecular Formula: C20H32. Mole Weight: 272.48. Catalog: APB70901632. | |
| Teprenone Impurity 26 (Geranylgeraniol) | Teprenone Impurity 26 (Geranylgeraniol). Uses: For analytical and research use. Group: Impurity standards. CAS No. 24034-73-9. Molecular Formula: C20H34O. Mole Weight: 290.49. Catalog: APB24034739. | |
| Teprenone Impurity 27 (Geranylnerol) | Teprenone Impurity 27 (Geranylnerol). Uses: For analytical and research use. Group: Impurity standards. CAS No. 57784-25-5. Molecular Formula: C20H34O. Mole Weight: 290.49. Catalog: APB57784255. | |
| Teprenone impurity 3 | Teprenone impurity 3. Uses: For analytical and research use. Group: Impurity standards. CAS No. 3796-69-8. Molecular Formula: C18H30O. Mole Weight: 262.44. Catalog: APB3796698. | |
| Teprenone Impurity 3 | One impurity of Teprenone, which could be used as an anti-ulcerative agent and has been found to induce the expression of HSP70, HSPB8, and HSPB1. Grades: > 95%. Molecular formula: C22H36O. Mole weight: 316.53. | |
| Teprenone impurity 30 | Teprenone impurity 30. Uses: For analytical and research use. Group: Impurity standards. CAS No. 3796-64-3. Molecular Formula: C23H38O. Mole Weight: 330.56. Catalog: APB3796643. | |
| Teprenone impurity 31 | Teprenone impurity 31. Uses: For analytical and research use. Group: Impurity standards. CAS No. 3879-24-1. Molecular Formula: C23H38O. Mole Weight: 330.56. Catalog: APB3879241. | |
| Teprenone impurity 32 | Teprenone impurity 32. Uses: For analytical and research use. Group: Impurity standards. CAS No. 3796-67-6. Molecular Formula: C23H38O. Mole Weight: 330.56. Catalog: APB3796676. | |
| Teprenone impurity 39 | Teprenone impurity 39. Uses: For analytical and research use. Group: Impurity standards. CAS No. 3796-63-2. Molecular Formula: C23H38O. Mole Weight: 330.56. Catalog: APB3796632. | |
| Teprenone impurity 4 | Teprenone impurity 4. Uses: For analytical and research use. Group: Impurity standards. CAS No. 3953-35-3. Molecular Formula: C18H30O. Mole Weight: 262.44. Catalog: APB3953353. | |
| Teprenone Impurity 4 | One impurity of Teprenone, which could be used as an anti-ulcerative agent and has been found to induce the expression of HSP70, HSPB8, and HSPB1. Synonyms: (5Z,9Z,13E)-Geranylgeranylacetone; (Z,Z,E)-6,10,14,18-Tetramethyl-5,9,13,17-nonadecatetraen-2-one. Grades: > 95%. CAS No. 3879-24-1. Molecular formula: C23H38O. Mole weight: 330.56. | |
| Teprenone impurity 41 | Teprenone impurity 41. Uses: For analytical and research use. Group: Impurity standards. CAS No. 3796-66-5. Molecular Formula: C23H38O. Mole Weight: 330.56. Catalog: APB3796665. | |
| Teprenone impurity 42 | Teprenone impurity 42. Uses: For analytical and research use. Group: Impurity standards. CAS No. 3879-25-2. Molecular Formula: C23H38O. Mole Weight: 330.56. Catalog: APB3879252. | |
| Teprenone Impurity 5 | One impurity of Teprenone, which could be used as an anti-ulcerative agent and has been found to induce the expression of HSP70, HSPB8, and HSPB1. Synonyms: (5Z,9Z,13Z)-Geranylgeranylacetone; (Z,Z,Z)-6,10,14,18-Tetramethyl-5,9,13,17-nonadecatetraen-2-one. Grades: > 95%. CAS No. 3796-67-6. Molecular formula: C23H38O. Mole weight: 330.56. | |
| Teprenone Impurity 6 | One impurity of Teprenone, which could be used as an anti-ulcerative agent and has been found to induce the expression of HSP70, HSPB8, and HSPB1. Grades: > 95%. Molecular formula: C22H36O. Mole weight: 316.53. | |
| Teprenone Impurity 7 | One impurity of Teprenone, which could be used as an anti-ulcerative agent and has been found to induce the expression of HSP70, HSPB8, and HSPB1. Grades: > 95%. Molecular formula: C22H36O. Mole weight: 316.53. | |
| Teprenone Impurity 8 | One impurity of Teprenone, which could be used as an anti-ulcerative agent and has been found to induce the expression of HSP70, HSPB8, and HSPB1. Grades: > 95%. Molecular formula: C23H38O2. Mole weight: 346.56. | |
| Teprenone Impurity 9 | One impurity of Teprenone, which could be used as an anti-ulcerative agent and has been found to induce the expression of HSP70, HSPB8, and HSPB1. Grades: > 95%. Molecular formula: C23H38O2. Mole weight: 346.56. | |
| Teprotide | Teprotide, a nonapeptide isolated from the snake Bothrops jararaca, is an angiotensin converting enzyme (ACE) inhibitor that inhibits the conversion of angiotensin I to angiotensin II and may potentiate some of the pharmacological actions of bradykinin. It used as an antihypertension agent. Synonyms: SQ20881; H-Pyr-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro-OH; L-pyroglutamyl-L-tryptophyl-L-prolyl-L-arginyl-L-prolyl-L-glutaminyl-L-isoleucyl-L-prolyl-L-proline; Teprotide; Bradykinin Potentiating Peptide 9a; BPP 9a; 5-Oxo-L-prolyl-L-tryptophyl-L-prolyl-L-arginyl-L-prolyl-L-glutaminyl-L-isoleucyl-L-prolyl-L-proline; Angiotensin Converting Enzyme Inhibitor. Grades: ≥95%. CAS No. 35115-60-7. Molecular formula: C53H76N14O12. Mole weight: 1101.26. | |
| Teprotumumab | Teprotumumab is an IGF-1 receptor (IGF-1R) blocking human monoclonal antibody. Teprotumumab has been approved for the treatment of thyroid eye disease. Synonyms: Tepezza. CAS No. 1036734-93-6. | |
| Teprotumumab | Teprotumumab is an IGF-1 receptor (IGF-1R) blocking human monoclonal antibody. Teprotumumab binds to the ligand binding extracellular α-subunit domain of IGF-1R. Teprotumumab inhibits TSH and IGF-1 action in fibrocytes. Teprotumumab attenuates TSH-dependent IL-6 and IL-8 expression and Akt phosphorylation. Teprotumumab can be used for thyroid-associated ophthalmopathy research [1]. Uses: Scientific research. Group: Inhibitory antibodies. CAS No. 1036734-93-6. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99165. | |
| Terameprocol | Terameprocol, a semi-synthetic tetra-methylated derivative of nordihydroguaiaretic acid (NDGA) and transcriptional inhibitor with potential antiviral, antiangiogenic, and antineoplastic activities. Terameprocol competes with the transcription factor Sp1 for specific Sp1 DNA binding domains within gene promoter regions during DNA synthesis. In virally-infected cells, blocking of the Sp1 binding site suppresses Sp1-regulated viral promoter activity and gene expression, thereby inhibiting viral transcription and replication. In tumor cells, blockage of Sp1 binding sites by this agent interferes with the transcription of the Sp1-dependant genes cyclin-dependant kinase (Cdc2), survivin, and vascular endothelial growth factor (VEGF), which are overexpressed in a variety of cancers. By suppressing Sp1-regulated transcription of these genes, terameprocol may reduce tumor angiogenesis and tumor cell proliferation and induce tumor cell apoptosis. Synonyms: meso-Tetra-O-methylnordihydroguaiaretic acid; EM-1421; EM1421; EM 1421; rel-4,4'-((2R,3S)-2,3-Dimethylbutane-1,4-diyl)bis(1,2-dimethoxybenzene); TMNDGA. Grades: >98%. CAS No. 24150-24-1. Molecular formula: C22H30O4. Mole weight: 358.47. | |
| Terameprocol | Terameprocol is a synthetic derivative of Nordihydroguaiaretic acid and a non-selective lipoxygenase inhibitor. Terameprocol has antiviral and antitumor effects [1] [2] [3]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: EM-1421. CAS No. 24150-24-1. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-10447. | |
| Terazosin | Terazosin, works by blocking the action of adrenaline on smooth muscle of the bladder and the blood vessel walls, is a selective alpha1-antagonist used for treatment of symptoms of benign prostatic hyperplasia (BPH). Uses: A selective alpha1-antagonist used for treatment of symptoms of benign prostatic hyperplasia (bph). Synonyms: [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(oxolan-2-yl)methanone. Grades: ≥98%. CAS No. 63590-64-7. Molecular formula: C19H25N5O4. Mole weight: 387.44. | |
| Terazosin EP impurity D | Terazosin EP impurity D. Uses: For analytical and research use. Group: Impurity standards. CAS No. 102714-74-9. Molecular Formula: C15H19N5O3. Mole Weight: 317.35. Catalog: APB102714749. | |
| Terazosin EP Impurity E | One impurity of Terazosin, which is a piperazine derivative and has been found to be an α-1-adrenergic blocker. Uses: An impurity of selective alpha 1 antagonists: terazosin (t105000) and prazosin (p702325). Synonyms: 1,4-Bis(4-amino-6,7-dimethoxy-2-quinazolinyl)piperazine; 2,2'-(Piperazine-1,4-diyl)bis(6,7-dimethoxyquinazolin-4-amine). CAS No. 102839-00-9. Molecular formula: C24H28N8O4. Mole weight: 492.53. | |
| Terazosin EP impurity F | Terazosin EP impurity F. Uses: For analytical and research use. Group: Impurity standards. CAS No. 109678-71-9. Molecular Formula: C19H27N5O4. Mole Weight: 389.46. Catalog: APB109678719. | |
| Terazosin EP impurity G | Terazosin EP impurity G. Uses: For analytical and research use. Group: Impurity standards. CAS No. 105356-89-6. Molecular Formula: C18H23N5O4. Mole Weight: 371.41. Catalog: APB105356896. | |
| Terazosin EP impurity H | Terazosin EP impurity H. Uses: For analytical and research use. Group: Impurity standards. CAS No. 105356-90-9. Molecular Formula: C18H23N5O4. Mole Weight: 373.41. Catalog: APB105356909. | |
| Terazosin EP impurity J | Terazosin EP impurity J. Uses: For analytical and research use. Group: Impurity standards. CAS No. 152551-75-2. Molecular Formula: C19H27N5O4. Mole Weight: 389.46. Catalog: APB152551752. | |
| Terazosin EP impurity K | Terazosin EP impurity K. Uses: For analytical and research use. Group: Impurity standards. CAS No. 19216-56-9. Molecular Formula: C19H21N5O4. Mole Weight: 383.41. Catalog: APB19216569. | |
| Terazosin EP impurity L | Terazosin EP impurity L. Uses: For analytical and research use. Group: Impurity standards. CAS No. 40172-95-0. Molecular Formula: C9H12N2O2. Mole Weight: 180.21. Catalog: APB40172950. | |
| Terazosin EP impurity M | Terazosin EP impurity M. Uses: For analytical and research use. Group: Impurity standards. CAS No. 31350-27-3. Molecular Formula: C14H14N2O4. Mole Weight: 274.28. Catalog: APB31350273. | |
| Terazosin EP impurity N | Terazosin EP impurity N. Uses: For analytical and research use. Group: Impurity standards. CAS No. 63074-07-7. Molecular Formula: C9H16N2O2. Mole Weight: 184.24. Catalog: APB63074077. | |
| Terazosin EP impurity O | Terazosin EP impurity O. Uses: For analytical and research use. Group: Impurity standards. CAS No. 547730-06-3. Molecular Formula: C14H22N2O4. Mole Weight: 282.34. Catalog: APB547730063. | |
| Terazosin EP Impurity O | One impurity of Terazosin, which is a piperazine derivative and has been found to be an α-1-adrenergic blocker. Synonyms: Terazosin Impurity 17. Grades: 95%. CAS No. 547730-06-3. Molecular formula: C14H22N2O4. Mole weight: 282.33. | |
| Terazosin EP Impurity O-RR | One impurity of Terazosin, which is a piperazine derivative and has been found to be an α-1-adrenergic blocker. Synonyms: Terazosin impurity 11-RR. Grades: 95%. Molecular formula: C14H22N2O4. Mole weight: 282.33. | |
| Terazosin HCl | Cas No. 63074-08-8. | |
| Terazosin HCl dihydrate | Terazosin HCl dihydrate. Group: Biochemicals. Grades: Highly Purified. CAS No. 70024-40-7. Pack Sizes: 50mg, 100mg, 250mg, 500mg, 1g. Molecular Formula: C19H25N5O4·ClH·2H2O. US Biological Life Sciences. | Worldwide |
| Terazosin hydrochloride | Terazosin hydrochloride is a quinazoline derivative and a competitive and orally active α1-adrenoceptor antagonist. Terazosin hydrochloride works by relaxing blood vessels and the opening of the bladder. Terazosin hydrochloride has the potential for benign prostatic hyperplasia (BPH) and high blood pressure treatment [1] [2] [3]. Uses: Scientific research. Group: Signaling pathways. CAS No. 63074-08-8. Pack Sizes: 10 mM * 1 mL; 50 mg; 100 mg. Product ID: HY-B0371F. | |
| Terazosin, Hydrochloride | An a-1-adrenergicblocker related to prazosin. Group: Biochemicals. Alternative Names: 1- (4-Amino-6, 7-dimethoxy-2-quinazolinyl) -4-[ (tetrahydro-2-furanyl) carbonxyl]piperazine, Hydrochloride. Grades: Highly Purified. CAS No. 63074-08-8. Pack Sizes: 1g, 5g. US Biological Life Sciences. | Worldwide |
| Terazosin hydrochloride dihydrate | Terazosin hydrochloride dihydrate is a quinazoline derivative and a competitive and orally active α1-adrenoceptor antagonist. Terazosin hydrochloride dihydrate works by relaxing blood vessels and the opening of the bladder. Terazosin hydrochloride dihydrate has the potential for benign prostatic hyperplasia (BPH) and high blood pressure treatment [1] [2] [3]. Uses: Scientific research. Group: Signaling pathways. CAS No. 70024-40-7. Pack Sizes: 10 mM * 1 mL; 50 mg; 100 mg. Product ID: HY-B0371A. | |
| Terazosin impurity 1 | Terazosin impurity 1. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1486464-41-8. Molecular Formula: C24H30Cl2N8O4. Mole Weight: 565.46. Catalog: APB1486464418. | |
| Terazosin Impurity B | One impurity of Terazosin, which is a piperazine derivative and has been found to be an α-1-adrenergicblocker. Synonyms: 6,7-Dimethoxy-2-(4-(tetrahydrofuran-2-carbonyl)piperazin-1-yl)quinazolin-4(1H)-one; 6,?7-Dimethoxy-2-[4-[(tetrahydro-2-furanyl)?carbonyl]?-1-piperazinyl]?-4(3H)?-quinazolinone. Grades: > 95%. CAS No. 1177261-73-2. Molecular formula: C19H24N4O5. Mole weight: 388.43. | |
Our database is helping our users find suppliers everyday.
